(Q35906614)

English

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis

scientific article published on 10 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giovanni Lughezzani

object named as

Giovanni Lughezzani

7

0 references

object named as

Andrew J Vickers

11

0 references

Pierre I Karakiewicz

10

object named as

Pierre I Karakiewicz

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

object named as

Maxine Sun

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Shahrokh Shariat

1

object named as

Shahrokh F Shariat

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6

object named as

Richard K Lee

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Thomas F Chromecki

3

object named as

Thomas F Chromecki

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

8

object named as

Mesut Remzi

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Caroline O. S. Savage

2

object named as

Caroline Savage

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Douglas S Scherr

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Michael J Marberger

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

10 January 2011

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

117

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

2892-2897

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3334293

11 July 2018

Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3334293

11 July 2018

Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3334293

11 July 2018

Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3334293

11 July 2018

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25903

21 January 2018

Net reclassification improvement and decision theory.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25903

21 January 2018

Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25903

21 January 2018

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25903

21 January 2018

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21692050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21692050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21692050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/21692050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21692050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21692050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.25903

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35906614&oldid=1859528506"